BCAB · BioAtla, Inc.
$3.09
-0.36 (-10.43%)
At close · Aug 14
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on our current operating plan, and along with our history of operating losses, our current cash and cash equivalents are not sufficient to fund our ongoing operations for a period of at least twelve months from the date the condensed consolidated financial statements included in this report are issued, and these circumstances raise substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Aug 13, 2026
Market Cap
$5.15M
Shares
1.67M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Jay M. Short | Chief Executive Officer, Co-founder, and Chairman of the Board of Directors | $879,248 |
| Eric Sievers | Chief Medical Officer | $584,408 |
| Richard Waldron | Chief Financial Officer | $516,180 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Jay M. Short | Chief Executive Officer, Cofounder, and Chairman of the Board of Directors | $1,952,798 |
| Eric Sievers | Chief Medical Officer | $961,075 |
| Richard Waldron | Chief Financial Officer | $881,700 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Jay M. Short | Chief Executive Officer, Cofounder, and Chairman of the Board of Directors | $3,301,346 |
| Eric Sievers | Chief Medical Officer | $1,316,844 |
| Scott Smith | Former President, Director | $1,272,682 |
| Richard Waldron | Chief Financial Officer | $1,235,412 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Jay M. Short | Chief Executive Officer, Cofounder, and Chairman of the Board of Directors | $2,544,382 |
| Scott Smith | Former President, Director | $1,713,430 |
| Eric Sievers | Chief Medical Officer | $1,153,473 |
| Richard Waldron | Chief Financial Officer | $1,131,625 |
| Christian Vasquez | Vice President of Finance, Corporate Controller and Secretary | $605,409 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Carolyn Anderson Short | Co-founder, Former Executive Vice President and Chief of Intellectual Property and Strategy | $7,372,646 |
| Jay M. Short | Chief Executive Officer, Founder and Chairman of the Board of Directors | $1,016,776 |
| Scott Smith | President | $798,888 |
| Richard Waldron | Chief Financial Officer | $593,514 |
| Eric Sievers | Chief Medical Officer | $552,616 |
| Christian Vasquez | Vice President of Finance, Corporate Controller and Secretary | $345,876 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Jay M. Short | Chief Executive Officer, Cofounder, and Chairman of the Board of Directors | $11,665,083 |
| Scott Smith | President | $8,985,628 |
| Carolyn Anderson Short | Co-founder, Former Executive Vice President and Chief of Intellectual Property and Strategy | $3,441,844 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Jay M. Short | Chief Executive Officer, Founder and Chairman of the Board of Directors | $991,463 |
| Scott Smith | President | $799,053 |
| Carolyn Anderson Short | Co-founder, Former Executive Vice President and Chief of Intellectual Property and Strategy | $776,569 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Chris Vasquez | Chief Financial Officer | Appointed | 2026-03-02 |
| Richard Waldron | Chief Financial Officer | Terminated | 2026-03-02 |
| Christian Vasquez | Chief Accounting Officer | Appointed | 2024-02-21 |
| Scott Smith | President | Resigned | 2023-02-27 |
| Christian Vasquez | SVP of Finance | Appointed | 2023-02-15 |
| Guy Levy | Board of Directors | Resigned | 2022-06-06 |
Key facts
CIK
1826892
CUSIP
09077B203
13F (30d)
21 filings
21 filers
Visit website
Investor relations